← Browse by Condition
Medical Condition
iga nephropathy igan
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06819826 Phase 3
Recruiting
A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
Enrollment
360 pts
Location
China
Sponsor
Biocity Biopharmaceutics Co., ...
NCT06926244
Recruiting
RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
Enrollment
800 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...